Dolby Laboratories, Inc.
DLB
$61.06
-$3.44-5.33%
NYSE
| 12/26/2025 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.34B | 1.35B | 1.35B | 1.32B | 1.32B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.34B | 1.35B | 1.35B | 1.32B | 1.32B |
| Cost of Revenue | 162.57M | 160.13M | 154.61M | 146.27M | 149.21M |
| Gross Profit | 1.18B | 1.19B | 1.19B | 1.17B | 1.17B |
| SG&A Expenses | 644.54M | 647.24M | 640.12M | 628.44M | 625.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.07B | 1.07B | 1.06B | 1.04B | 1.04B |
| Operating Income | 267.50M | 279.97M | 289.23M | 282.99M | 277.49M |
| Income Before Tax | 289.04M | 303.49M | 321.55M | 316.20M | 317.70M |
| Income Tax Expenses | 46.93M | 46.99M | 55.85M | 57.38M | 52.89M |
| Earnings from Continuing Operations | 242.10 | 256.49 | 265.70 | 258.82 | 264.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.58M | -1.47M | -1.45M | -2.19M | -2.14M |
| Net Income | 240.52M | 255.02M | 264.26M | 256.63M | 262.67M |
| EBIT | 267.50M | 279.97M | 289.23M | 282.99M | 277.49M |
| EBITDA | 357.11M | 367.79M | 376.41M | 366.56M | 357.54M |
| EPS Basic | 2.51 | 2.66 | 2.76 | 2.68 | 2.75 |
| Normalized Basic EPS | 2.00 | 2.06 | 2.13 | 2.12 | 2.09 |
| EPS Diluted | 2.48 | 2.63 | 2.72 | 2.64 | 2.71 |
| Normalized Diluted EPS | 1.98 | 2.03 | 2.10 | 2.09 | 2.06 |
| Average Basic Shares Outstanding | 383.32M | 383.47M | 383.24M | 383.03M | 382.41M |
| Average Diluted Shares Outstanding | 387.74M | 388.36M | 388.11M | 388.17M | 387.56M |
| Dividend Per Share | 1.38 | 1.35 | 1.32 | 1.29 | 1.26 |
| Payout Ratio | 53.80% | 49.64% | 46.78% | 47.03% | 44.76% |